Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Pioglitazone & Type 2 diabetes (T2D), the FDA has granted approval to pioglitazone as an oral antidiabetic medication. It is intended to be used alongside diet and exercise to enhance glycemic control in adults diagnosed with type 2 diabetes. Pioglitazone is available both as a standalone product and in fixed-dose combinations. Additionally, generic versions of pioglitazone tablets have received approval in various strengths, such as 15, 30, and 45 mg, for the treatment of type 2 diabetes.
[pioglitazone-marketed-actos-actoplus-met-duetact-and-oseni-informa…